A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Clinical trial NCT06173011 · UNKNOWN
Trial details
- NCT number
- NCT06173011
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2024-07-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.